HPLE EXCIPIENTS
Live / Registered — Registered (as of 26 Jan 2021)
What this means for you
Registered since 26 Jan 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 26 Jan 2027, and its filing window is open now).
Record
- Serial number
- 87608792
- Registration number
- 6257475
- Mark type
- Word mark
- Filed
- 14 Sept 2017
- Published for opposition
- 03 Jul 2018
- Registered
- 26 Jan 2021
- Next maintenance filing
- §8 declaration of use, due by 26 Jan 2027 (grace period to 26 Jul 2027)
- Attorney of record
- Paul C. Llewellyn
Goods and services
- Class 001 — Chemicals: Chemicals and biochemicals for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, finished drug products, parenteral drugs and therapies; Chemicals and biochemicals for use in biotechnological product development and manufacturing processes; excipients and active ingredients for use in development, formulation and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, injectable formulations, pharmaceutical intermediaries and drug formulations; chemicals, biochemicals, stabilizers, catalysts, enzymes, formulation ingredients, additives, drug delivery molecules and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; active pharmaceutical ingredients for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; formulation ingredients, additives, drug delivery molecules, and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; pharmaceutical intermediates for use in the pharmaceutical and biopharmaceutical industry; biochemical excipients for use in the pharmaceutical and biopharmaceutical industry; biochemical catalysts; biochemical preservers and protectors for use in the pharmaceutical and biopharmaceutical industry
- Class 042 — Scientific and technological services: Biochemical research and development; Chemical, biochemical, biological and bacteriological research and analysis; Drug discovery services; Pharmaceutical drug development services; Product research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines
Owner
- Pfanstiehl, Inc., Waukegan, IL
- Pfanstiehl, Inc., Waukegan, IL
- Pfanstiehl, Inc., Waukegan, IL
Prosecution history
- 26 Jan 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 Jan 2021 — REGISTERED-PRINCIPAL REGISTER
- 23 Dec 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Dec 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Dec 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Dec 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Dec 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Oct 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Oct 2020 — NON-FINAL ACTION E-MAILED
- 02 Oct 2020 — SU - NON-FINAL ACTION - WRITTEN
- 15 Sept 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Sept 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Aug 2020 — USE AMENDMENT FILED
- 14 Sept 2020 — SOU EXTENSION 4 GRANTED
- 28 Aug 2020 — SOU EXTENSION 4 FILED